NCT05024214 2026-03-25Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT06698965 2024-11-21Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinShanghai Chest HospitalPhase 2 Recruiting52 enrolled